Elisei R - Search Results

1

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

Schlumberger MJ, Elisei R, Bastholt L, Wirth LJ, Martins RG, Locati LD, Jarzab B, Pacini F, Daumerie C, Droz JP, Eschenberg MJ, Sun YN, Juan T, Stepan DE, Sherman SI. Schlumberger MJ, et al. Among authors: elisei r. J Clin Oncol. 2009 Aug 10;27(23):3794-801. doi: 10.1200/JCO.2008.18.7815. Epub 2009 Jun 29. J Clin Oncol. 2009. PMID: 19564535 Clinical Trial.

2

Expression of calcitonin gene-related peptide in medullary thyroid cancer.

Pacini F, Fugazzola L, Basolo F, Elisei R, Pinchera A. Pacini F, et al. Among authors: elisei r. J Endocrinol Invest. 1992 Jul-Aug;15(7):539-42. doi: 10.1007/BF03348802. J Endocrinol Invest. 1992. PMID: 1447491

3

Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.

Pacini F, Basolo F, Elisei R, Fugazzola L, Cola A, Pinchera A. Pacini F, et al. Among authors: elisei r. Am J Clin Pathol. 1991 Mar;95(3):300-8. doi: 10.1093/ajcp/95.3.300. Am J Clin Pathol. 1991. PMID: 1996540

4

Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.

Pacini F, Elisei R, Anelli S, Basolo F, Cola A, Pinchera A. Pacini F, et al. Among authors: elisei r. Cancer. 1989 Mar 15;63(6):1189-95. doi: 10.1002/1097-0142(19890315)63:6<1189::aid-cncr2820630625>3.0.co;2-j. Cancer. 1989. PMID: 2563668

5

Thyroid cancer in children and adolescents.

Ceccarelli C, Pacini F, Lippi F, Elisei R, Arganini M, Miccoli P, Pinchera A. Ceccarelli C, et al. Among authors: elisei r. Surgery. 1988 Dec;104(6):1143-8. Surgery. 1988. PMID: 3194841

6

Circulating neuron-specific enolase in medullary thyroid cancer.

Pacini F, Elisei R, Anelli S, Gasperini L, Schipani E, Pinchera A. Pacini F, et al. Among authors: elisei r. Int J Biol Markers. 1986 May-Aug;1(2):85-8. doi: 10.1177/172460088600100205. Int J Biol Markers. 1986. PMID: 3429944

7

Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C, Pinchera A. Pacini F, et al. Among authors: elisei r. J Nucl Med. 1987 Dec;28(12):1888-91. J Nucl Med. 1987. PMID: 3681445 Free article.

8

Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.

Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A. Pacini F, et al. Among authors: elisei r. J Clin Endocrinol Metab. 1994 Apr;78(4):826-9. doi: 10.1210/jcem.78.4.8157706. J Clin Endocrinol Metab. 1994. PMID: 8157706

9

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.

Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F. Romei C, et al. Among authors: elisei r. J Clin Endocrinol Metab. 1996 Apr;81(4):1619-22. doi: 10.1210/jcem.81.4.8636377. J Clin Endocrinol Metab. 1996. PMID: 8636377

10

RET proto-oncogene mutations in thyroid carcinomas: clinical relevance.

Pacini F, Elisei R, Romei C, Pinchera A. Pacini F, et al. Among authors: elisei r. J Endocrinol Invest. 2000 May;23(5):328-38. doi: 10.1007/BF03343732. J Endocrinol Invest. 2000. PMID: 10882153 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page